Expression of inducible nitric oxide synthase after endothelial denudation of the rat carotid artery role of platelets

Circulation Research

Volumn 83, Issue 11, 1998, Pages 1080-1087

  González Fernández, Fernando ^a   López Farré, Antonio ^a   Rodríguez Feo, Juan A ^a   Farré, Jerónimo ^b   Guerra, José ^a   Fortes, Jose ^b   Millas, Inmaculada ^a   García Durán, Margarita ^a   Rico, Luis ^a   Mata, Pedro ^c   Sánchez De Miguel, Lourdes ^a   Casado, Santos ^a  

^a Nephrology   (Spain)

^b Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^c NONE

Author keywords

Angioplasty; Endothelium derived factor nitric oxide; Glycoprotein IIb IIIa; Nitric oxide synthase; Platelet

Indexed keywords

FIBRINOGEN RECEPTOR; NITRIC OXIDE SYNTHASE; PLATELET DERIVED GROWTH FACTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL INJURY; CAROTID ARTERY; CONTROLLED STUDY; ENDOTHELIUM CELL; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER; THROMBOCYTE ACTIVATION;

EID: 0344193130     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.83.11.1080     Document Type: Article

References (38)

1. Neumann FJ, Ott I, Gawaz M, Puchner G, Schömig A. Neutrophil and platelet activation at balloon-injured coronary artery plaque in patients undergoing angioplasty. J Am Coll Cardiol. 1996;27:819-824.
2. Clowes AW, Reidy MA, Clowes MM. Kinetics of cellular proliferation after arterial injury, I: smooth muscle growth in the absence of endothelium. Lab Invest. 1983;49:327-333.
3. Liu MW, Roubin GS, King SB. Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia. Circulation. 1989;79:1374-1387.
4. Fishman JA, Ryan GB, Karnovsky MJ. Endothelial regeneration in the rat carotid artery and the significance of endothelial denudation in the pathogenesis of myointimal thickening. Lab Invest. 1975;32:339-351.
5. Moncada S, Palmer RMJ, Higgs A. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev. 1991;43:109-141.
6. López-Farré A, Caramelo C, Esteban A, Alberola ML, Millás I, Montón M, Casado S. Effects of aspirin on platelet-neutrophil: role of nitric oxide and endothelin-1. Circulation. 1995;91:2080-2088.
7. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A. 1991;88:587-590.
8. Trachtman H, Futterweit S, Singhal P. Nitric oxide modulates the synthesis of extracellular matrix proteins in cultured rat mesangial cells. Biochem Biophys Res Commun. 1995;207:120-125.
9. Sessa WC. The nitric oxide synthase family of proteins. J Vasc Res. 1994;31:131-143.
10. Joly GA, Schini VB, Vanhoutte PM. Balloon injury and interleukin-1β induce nitric oxide synthase activity in rat carotid arteries. Circ Res. 1992;71:331-338.
11. López-Farré A, Mosquera JR, Sánchez de Miguel L, Millás I, de Frutos T, Montón M, Sierra MP, Riesco A, Casado S. Endothelial cells inhibit NO generation by vascular smooth cells. Role of transforming growth factor-β. Arterioscler Thromb Vasc Biol. 1996;16:1263-1268.
12. Montón M, López-Farré A, Mosquera JR, Sánchez de Miguel L, García-Durán M, Sierra MP, Bellver T, Rico L, Casado S. Endogenous angiotensin II produced by endothelium regulates interleukin-1β-stimulated nitric oxide generation in rat isolated vessels. Hypertension. 1997;30:1191-1197.
13. Laemmli NK. Change of structural proteins during the assembly of the head of bacteriophage t4. Nature. 1970;227:680-685.
14. McGuire PG, Orkin RW. Isolation of rat aortic endothelial cells by primary explant techniques and their phenotypic modulation by defined substrates. Lab Invest. 1987;57:94-104.
15. Cernadas MR, Sánchez de Miguel L, García-Durán M, González-Fernández F, Millás I, Montón M, Rodrigo J, Rico L, Fernández P, de Frutos T, Rodríguez-Feo JA, Guerra J, Caramelo C, Casado S, López-Farré A. Expression of constitutive and inducible nitric oxide synthases in the vascular wall of young and aging rats. Circ Res. 1998; 83:279-286.
16. Merhi Y, Provost P, Guidoin R, Latour JG. Importance of platelets in neutrophil adhesion and vasoconstriction after deep carotid arterial injury by angioplasty in pigs. Arterioscler Thromb Vasc Biol. 1997;17: 1185-1191.
17. López-Farré A, Riesco A, Digiuni E, Mosquera JR, Caramelo C, Sánchez de Miguel L, Millás I, de Frutos T, Cernadas MR, Montón M, Alonso J, Casado S. Aspirin-stimulated nitric oxide production by neutrophils after acute myocardial ischemia in rabbits. Circulation. 1996;94:83-87.
18. Scott-Burden T, Schini VB, Elizondo E, Junquero DC, Vanhoutte PM. Platelet-derived growth factor suppresses and fibroblast growth factor enhances cytokine-induced production of nitric oxide by cultured smooth muscle cells. Circ Res. 1992;71:1088-1100.
19. Maresta A, Balducelli M, Cantini L, Casari A, Chioin R, Fabbri M, Fontanelli A, Monici Petri PA, Repetto S, De Servi S, for the STARC Investigators. Trapidil (triazolopyrimidine), a platelet-derived growth factor antagonist, reduces restenosis after percutaneous transluminal coronary angioplasty. Circulation. 1994;90:2710-2715.
20. Pulford KA, Rigney EM, Micklem KJ, Jones M, Stross WP, Gatter KC, Mason DY. KP1 : a new monoclonal antibody that detects a monocyte/ macrophage associated antigen in routinely processed tissues sections. J Clin Pathol. 1989;42:414-421.
21. Hansson GK, Geng YJ, Holm J, Hardhammar P, Wennmalm A, Jennische E. Arterial smooth muscle cells express nitric oxide synthase in response to endothelial injury. J Exp Med. 1994;180:733-738.
22. Warner SJ, Libby P. Human vascular smooth muscle cells: target for and source of tumor necrosis factor. J Immunol. 1989;142:100-109.
23. Schini VB, Junquero DC, Scott-Burden T, Vanhoutte PM. Interleukin-1β induces the production of an L-arginine derived relaxing factor from cultured smooth muscle cells from rat aorta. Biochem Biophys Res Commun. 1991;176:114-121.
24. Schwartz SM, Reidy MA. Restenosis: an assessment of factors important in arterial occlusion. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and Coronary Arterial Disease. Philadelphia, Pa: Lippincott-Raven: 1996:701-714.
25. Mickelson JK, Lakkis NM, Villareal-Levy G, Hughes BJ, Smith CW. Leukocyte activation with platelet adhesion after coronary angioplasty: a mechanism for recurrent disease? J Am Coll Cardiol. 1996;28:345-353.
26. Coller BS. The role of platelets in arterial thrombosis and the rationale for blockade of platelet GP IIb-IIIa receptors as antithrombotic therapy. Eur Heart J. 1995;16:11-15.
27. Marcus AJ. Platelet activation. In: Fuster V, Ross R, Topol EJ, eds. Atherosclerosis and Coronary Artery Disease. Philadelphia, Pa. Lippincott-Raven; 1996:607-637.
28. EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med. 1994;330:956-961.
29. Kaida T, Matsuno H, Niwa M, Kozawa O, Miyata H, Uematsu T. Antiplatelet effect of FK633, a platelet glycoprotein IIb-IIIa antagonist, on thrombus formation and vascular patency after thrombolysis in the injured hamster carotid artery. Thromb Haemost. 1997;77:562-567.
30. Fingerle J, Johnson R, Clowes AW, Majesky MW, Reidy MA. Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery. Proc Natl Acad Sci U S A. 1989;86: 8412-8416.
31. Ross P. Platelet-derived growth factor. Lancet. 1989;1:1179-1182.
32. Durante W, Schini VB, Kroll MH, Catovsky S, Scott-Burden T, White JG, Vanhoutte PM, Schafer AI. Platelets inhibit the induction of nitric oxide synthesis by interleukin-1β in vascular smooth muscle cells. Blood. 1994;83:1831-1838.
33. Wilentz JR, Sanborn TA, Haudenschild CC, Valeri CR, Ryan TJ, Faxon DP. Platelet accumulation in experimental angioplasty: time course and relation to vascular injury. Circulation. 1987;75:636-642.
34. Fukumoto Y, Shimokawa H, Kozai T, Kadokami T, Kuwata K, Yonemitsu Y, Kuga T, Egashira K, Sueishi K, Takeshita A. Vasculoprotective role of inducible nitric oxide synthase at inflammatory coronary lesions induced by chronic treatment with interleukin-1β in pigs in vivo. Circulation. 1997;96:3104-3111.
35. Palmer RM, Bridge L, Foxwell NA, Moncada S. The role of nitric oxide in endothelial damage and its inhibition by glucocorticoids. J Pharmacol. 1992;105:11-12.
36. López-Farré A, Sánchez de Miguel L, Caramelo C, Gomez-García J, García R, Mosquera JR, de Frutos T, Millás I, Rivas F, Echezarreta G, Casado C. Role of nitric oxide in the autocrine control of growth and apoptosis of endothelial cells. Am J Physiol. 1997;272:H760-H768.
37. Asahara T, Bauters C, Pastore C, Kearney M, Rossow S, Bunting S, Ferrara N, Symes JF, Isner JM. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. Circulation. 1995;91: 2793-2801.
38. Kessler P, Banersads J, Busse R, Schini-Kerth VB. Inhibition of inducible nitric oxide synthase restores endothelium-dependent relaxations in proinflammatory mediator-induced blood vessel. Artheroscler Thromb Vasc Biol. 1997;17:1746-1755.